FilingSEC EDGARF-3/A
China SXT Resets Floor Price to $0.20 Under Securities Purchase Agreement
· SEC accepted
StageContract Amendment
Filing content
China SXT Pharmaceuticals entered into an amendment to its Securities Purchase Agreement to reset the floor price for share issuances from $16.00 to $0.20.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…